Rx RadioRx Radio
HomePodcastResourcesShopNewsBusinessTechnologyClinical PracticeDrug Pricing & Access
HomePodcastResourcesShopArticlesCategoriesSearchAbout

Categories

NewsBusinessTechnologyClinical PracticeDrug Pricing & AccessEducationGlobal HealthLaw & ComplianceLeadership & DevelopmentManaged CarePatient Care & CounselingPublic HealthR&D
Rx RadioRx Radio

Leading the conversation in pharmacy

Navigation

  • Home
  • Podcast
  • Resources
  • Shop
  • Articles
  • Categories
  • Search

Categories

  • News
  • Business
  • Technology
  • Clinical Practice
  • Drug Pricing & Access
  • Education
  • Global Health

Company

  • About
  • Privacy Policy
  • Terms of Service

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Threads

© 2026 Rx Radio. All rights reserved.

PrivacyTerms
  1. Home
  2. Categories
  3. Drug Pricing & Access

Drug Pricing & Access

Pfizer Withdraws Oxbryta from Market Due to Safety Concerns

Pfizer Withdraws Oxbryta from Market Due to Safety Concerns

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost

CVS Health will cover Opill, the first FDA-approved over-the-counter birth control pill, at no cost through CVS Caremark plans, expanding contraceptive access nationwide.